Last €132.80 EUR
Change Today +3.15 / 2.43%
Volume 337.3K
SOLB On Other Exchanges
EN Brussels
As of 11:35 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

solvay sa (SOLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/27/15 - €133.30
52 Week Low
01/6/15 - €104.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SOLVAY SA (SOLB)

Related News

No related news articles were found.

solvay sa (SOLB) Related Businessweek News

No Related Businessweek News Found

solvay sa (SOLB) Details

Solvay SA is engaged in the chemical and plastic businesses worldwide. It operates in five segments: Advanced Formulations, Advanced Materials, Performance Chemicals, Functional Polymers, and Corporate & Business Services. The company offers chemical products, including advanced materials, barium strontium, calcium chloride, caustic soda, chlorinated products, fluor, peroxygen products, polyglycerols, precipitated calcium carbonate, soda ash, and sodium bicarbonate. It also provides specialty polymers, such as Spire ultra polymers, Solviva biomaterials, sulfone polymers, high-performance polyamides, liquid crystal polymers, high-barrier polymers, specialties, fluorinated fluids, fluoroelastomers/perfluoroelastomers, partially-fluorinated polymers, fluoropolymer coatings, fully-fluorinate polymers, polymer processing aids, and cross-linkable compounds; and vinyls comprising Benvic plasticized PVC compounds, Benvic PVC alloys, Benvic rigid PVC compounds, Nidacell, SolVin copolymers, SolVin general purpose, SolVin specialties, and Vinyloop regenerated PVC. In addition, the company offers additives, diphenols and derivatives, engineering plastics, fluorinated compounds, intermediates, phosphorus derivatives, polyamide fibers, precipitated silica, rare earths, mixed oxides, aluminas, solvents, specialty polymers and monomers, sulfuric acid, surfactants, textile yarns, staple fiber, and industrial yarns. Further, it provides energy services comprising energy optimization and carbon dioxide emissions reduction services; and eco services, such as acetate tow and sulfuric acid regeneration services. The company’s products are used in consumer goods and healthcare; automotive and aeronautics; building and construction; electrical and electronics; agro, feed, and food; energy and environment; and industrial applications. Solvay SA was founded in 1863 and is based in Brussels, Belgium.

29,400 Employees
Last Reported Date: 11/13/14
Founded in 1863

solvay sa (SOLB) Top Compensated Officers

Chief Executive Officer, Director, Member of ...
Total Annual Compensation: €2.1M
Compensation as of Fiscal Year 2013.

solvay sa (SOLB) Key Developments

Solvay SA Seeks To Sell Its Austrian Plant In Ebensee

Solvay SA (ENXTBR: SOLB) may make another attempt to sell its Austrian plant in Ebensee. The group is considering various options for its PCC assets and the sale is one of them.

Solvay and TSO3 Inc. Jointly Announce Premarket Clearance for TSO3's new STERIZONE VP4 Sterilization System

Solvay and TSO3 Inc. jointly announced that, as part of the U.S. FDA's 510(k) premarket clearance for TSO3's new STERIZONE VP4 Sterilization System received in December 2014, light weight instrument trays made of Solvay Specialty Polymer's Radel polyphenylsulfone (PPSU) resin demonstrate strong compatibility for sterilizing a wide range of medical devices. The STERIZONE VP4 Sterilizer developed by TSO3 is a low-temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone. It is the only system to have received FDA's premarket clearance for dual sterilant processes. It can sterilize a large number and wide range of compatible devices in a cost-effective, error-free single cycle. TSO3's unique Dynamic Sterilant Delivery System automatically adjusts the quantity of injected sterilant based on the load composition, weight and temperature. With its large, 75-pound (34-kilogram) capacity and short cycle time, the STERIZONE VP4 Sterilizer can enhance throughput and lower sterilization costs. Solvay will be showcasing its broad selection of high-performance medical-grade polymers for medical devices at Medical Design & Manufacturing (MD&M) West 2015 in booth #1906, from February 10-12, 2015.

Solvay SA, Q4 2014 Earnings Call, Feb 26, 2015

Solvay SA, Q4 2014 Earnings Call, Feb 26, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SOLB:BB €132.80 EUR +3.15

SOLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Eastman Chemical Co $75.28 USD -0.0073
Kerry Group PLC €65.00 EUR +0.14
Merck KGaA €92.20 EUR +0.376
Nippon Paint Holdings Co Ltd ¥4,150 JPY -70.00
Novozymes A/S kr323.50 DKK -0.80
View Industry Companies

Industry Analysis


Industry Average

Valuation SOLB Industry Range
Price/Earnings 26.7x
Price/Sales 0.9x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLVAY SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at